Corbus Pharmaceuticals is a clinical-stage precision biotechnology enterprise dedicated to discovering, licensing, and developing innovative medicines for serious illnesses, with a primary strategic emphasis on oncology and metabolic diseases. The company leverages established biological pathways to advance targeted drug candidates—such as antibody-drug conjugates and specialized small molecules—through rigorous clinical trials to deliver breakthrough treatment options for patients with significant unmet medical needs.